Table IV.

Mortality risk according to triglycerides derived from the Cox regression analysis shown as the hazard ratio (HR), p-value and the 95% confidence interval (95% CI).

		HR	p-value	95% CI		HR	p-value	95% CI
Parameter	n	Males			n	Females
50–60 years		N = 18 207; C = 1001				N = 18 210; C = 544
Trig < 1 mmol/L1	4390				5936
Trig 1–1.39 mmol/L	4968	0.92	0.337	0.77–1.10	5561	1.34	0.017	1.05–1.71
Trig 1.4 –1.69 mmol/L	1907	0.83	0.125	0.65–1.05	1836	1.56	0.005	1.15–2.13
Trig ≥ 1.7 mmol/L	6942	1.02	0.809	0.87–1.20	4877	1.96	< 0.001	1.55 –2.48
Statin	5402	0.59	< 0.001	0.51–0.68	5002	0.58	< 0.001	0.48–0.71
School 12–15 years		0.62	< 0.001	0.54–0.70		0.69	< 0.001	0.58–0.82
School ≥ 15 years		0.54	0.003	0.36–0.81		0.60	0.108	0.32–1.12
60–70 years		N = 14 079; C = 1560				N = 14 537; C = 1057
Trig < 1 mmol/L1	3826				4004
Trig 1–1.39 mmol/L	4328	1.10	0.167	0.96–1.26	4661	1.04	0.651	0.88–1.23
Trig 1.4 –1.69 mmol/L	1591	1.01	0.935	0.84–1.21	1607	1.35	0.005	1.10–1.66
Trig ≥ 1.7 mmol/L	4334	1.15	0.039	1.01–1.32	4265	1.25	0.010	1.05–1.48
Statin	5066	0.56	< 0.001	0.50–0.62	5354	0.52	< 0.001	0.46–0.60
School 12–15 years		0.81	< 0.001	0.73–0.89		0.69	< 0.001	0.61–0.79
School ≥ 15 years		0.50	< 0.001	0.34–0.72		0.69	0.092	0.45–1.06
> 70 years		N = 7612; C = 2134				N = 9266; C = 1738
Trig < 1 mmol/L1	2480				2256
Trig 1–1.39 mmol/L	2518	0.97	0.582	0.87–1.08	3223	1.08	0.235	0.95–1.23
Trig 1.4–1.69 mmol/L	788	0.91	0.215	0.78–1.06	1162	1.17	0.060	0.99–1.38
Trig ≥ 1.7 mmol/L	1826	0.91	0.113	0.81–1.02	2625	1.12	0.106	0.98–1.28
Statin	2597	0.59	< 0.001	0.54–0.65	3159	0.54	< 0.001	0.49–0.61
School 12–15 years		0.82	< 0.001	0.75–0.89		0.83	0.001	0.74–0.93
School ≥ 15 years		0.72	0.011	0.55–0.92		0.65	0.043	0.42–0.99

Notes: N = total numbers in the specific age and sex group, C = cases (died in the study period more than one year after inclusion) and n = numbers in each LDL-C or numbers receiving statin after inclusion. ¹Trig group < 1.0 mmol/L is the reference group and only the numbers in this group are therefore reported.